These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 27116088

  • 1. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP, Cohen C, Hanley KZ, Li XB.
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [Abstract] [Full Text] [Related]

  • 2. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F, Wang L, Zhang W, Lyu S, Niu Y.
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [Abstract] [Full Text] [Related]

  • 3. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT, Koerner FC, Lerwill MF.
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
    Zhang JL, Zhang HY, Wei B, Lang ZQ, Bu H.
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314
    [Abstract] [Full Text] [Related]

  • 7. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
    Grin A, O'Malley FP, Mulligan AM.
    Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S, Wei B, Zhang H, Qing M, Bu H.
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
    Mao X, Qiao Z, Fan C, Guo A, Yu X, Jin F.
    Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
    [Abstract] [Full Text] [Related]

  • 14. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
    Yu BH, Li BZ, Zhou XY, Shi DR, Yang WT.
    Diagn Pathol; 2018 May 30; 13(1):36. PubMed ID: 29848352
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
    Rammal R, Goel K, Elishaev E, Rinda Soong T, Jones MW, Zhao C, Clark BZ, Carter GJ, Yu J, Fine JL, Villatoro TM, Harinath L, Bhargava R.
    Am J Clin Pathol; 2022 Nov 03; 158(5):616-625. PubMed ID: 36000970
    [Abstract] [Full Text] [Related]

  • 17. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: an immunohistochemical study.
    Umekita Y, Yoshida H.
    Pathol Int; 2000 Jul 03; 50(7):527-30. PubMed ID: 10886733
    [Abstract] [Full Text] [Related]

  • 18. p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.
    Mao XY, Fan CF, Zheng HC, Wei J, Yao F, Jin F.
    J Exp Clin Cancer Res; 2010 Aug 16; 29(1):112. PubMed ID: 20712900
    [Abstract] [Full Text] [Related]

  • 19. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N, Sun ZZ, Li F, Cao YW, Zhao CX, Liang WH, Sun HP, Li HA, Fu XG.
    Zhonghua Bing Li Xue Za Zhi; 2011 May 16; 40(5):324-9. PubMed ID: 21756827
    [Abstract] [Full Text] [Related]

  • 20. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H, Hufnagl P, Kaufmann O, Krause M, Winzer KJ.
    Anal Quant Cytol Histol; 2000 Jun 16; 22(3):206-12. PubMed ID: 10872036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.